153 related articles for article (PubMed ID: 12219004)
1. Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis.
Lowy AM; Knight J; Groden J
Surgery; 2002 Aug; 132(2):141-8. PubMed ID: 12219004
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
Yang SZ; Kohno N; Kondo K; Yokoyama A; Hamada H; Hiwada K; Miyake M
Int J Oncol; 1999 Dec; 15(6):1109-15. PubMed ID: 10568816
[TBL] [Abstract][Full Text] [Related]
3. Alterations of E-cadherin and beta-catenin in gastric cancer.
Huiping C; Kristjansdottir S; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
BMC Cancer; 2001; 1():16. PubMed ID: 11747475
[TBL] [Abstract][Full Text] [Related]
4. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
5. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
7. Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin.
Sasaki CY; Lin H; Morin PJ; Longo DL
Cancer Res; 2000 Dec; 60(24):7057-65. PubMed ID: 11156412
[TBL] [Abstract][Full Text] [Related]
8. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines.
Mialhe A; Levacher G; Champelovier P; Martel V; Serres M; Knudsen K; Seigneurin D
J Urol; 2000 Sep; 164(3 Pt 1):826-35. PubMed ID: 10953163
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
[TBL] [Abstract][Full Text] [Related]
11. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
12. Requirement of protein kinase Calpha, extracellular matrix remodeling, and cell-matrix interaction for transforming growth factorbeta-regulated expression of E-cadherin and catenins.
Wang H; Chakrabarty S
J Cell Physiol; 2001 May; 187(2):188-95. PubMed ID: 11267998
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH
Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity.
Stockinger A; Eger A; Wolf J; Beug H; Foisner R
J Cell Biol; 2001 Sep; 154(6):1185-96. PubMed ID: 11564756
[TBL] [Abstract][Full Text] [Related]
15. Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells.
Alper O; De Santis ML; Stromberg K; Hacker NF; Cho-Chung YS; Salomon DS
Int J Cancer; 2000 Nov; 88(4):566-74. PubMed ID: 11058872
[TBL] [Abstract][Full Text] [Related]
16. Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
Nam JS; Ino Y; Sakamoto M; Hirohashi S
Jpn J Cancer Res; 2002 Sep; 93(9):1020-8. PubMed ID: 12359056
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
Williams CL; Noti JD
Int J Oncol; 2001 Dec; 19(6):1227-33. PubMed ID: 11713593
[TBL] [Abstract][Full Text] [Related]
18. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
Wong AS; Gumbiner BM
J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.
Kim K; Pang KM; Evans M; Hay ED
Mol Biol Cell; 2000 Oct; 11(10):3509-23. PubMed ID: 11029052
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the cadherin-catenin cell adhesion system in cancers.
Kanai Y; Oda T; Shimoyama Y; Ochiai A; Oyama T; Yoshiura K; Akimoto S; Yamada T; Hirohashi S
Princess Takamatsu Symp; 1994; 24():51-62. PubMed ID: 8983063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
